Cachexia in Cancer and Chronic Disease

Cachexia is a complex metabolic syndrome of ongoing muscle loss, with or without fat loss, driven by an underlying illness such as cancer, heart failure, or chronic kidney or lung disease. This topic explains how cachexia is defined and distinguished from simple undernutrition, and why it often resists ordinary nutritional support, framed as reference material rather than treatment guidance.

Definition

Cachexia is a multifactorial syndrome defined by ongoing loss of skeletal muscle mass — with or without loss of fat mass — that cannot be fully reversed by conventional nutritional support and that arises in the setting of an underlying illness, typically accompanied by systemic inflammation, anorexia, and altered metabolism.

Scope

The topic covers the consensus definitions of cachexia, its inflammatory and catabolic mechanisms, how it differs from starvation and from sarcopenia, and why it is partly refractory to feeding. It is reference content on a recognised clinical syndrome and does not offer diagnostic thresholds for individual patients or therapeutic recommendations.

Core questions

• How is cachexia defined, and how do the consensus definitions differ?
• Why does cachexia resist ordinary nutritional support?
• How does cachexia differ from starvation and from sarcopenia?
• What roles do inflammation and tumour-host signalling play in muscle and fat loss?

Key concepts

• Refractoriness to nutritional support
• Systemic inflammation and pro-inflammatory cytokines
• Anorexia-cachexia
• Skeletal-muscle proteolysis
• Pre-cachexia, cachexia, and refractory cachexia stages
• Cancer versus cardiac and renal cachexia

Mechanisms

Cachexia arises when an underlying disease provokes systemic inflammation and neuroendocrine activation — an extension of the metabolic response to injury described by Cuthbertson — that together suppress appetite, raise energy expenditure, and accelerate skeletal-muscle proteolysis (Cuthbertson, 1942). Pro-inflammatory cytokines and tumour-host signalling drive both muscle and adipose loss through multi-organ crosstalk, which is why cachexia is increasingly understood as a systemic rather than purely nutritional disorder (Argilés et al., 2014). Because these catabolic drivers persist, supplying more food alone cannot fully reverse the muscle loss, a defining feature captured in the cross-disease definition of Evans and colleagues (Evans et al., 2008) and operationalised for cancer in the staged international consensus of Fearon and colleagues, which classifies pre-cachexia, cachexia, and refractory cachexia (Fearon et al., 2011).

Clinical relevance

Cachexia is a recognised syndrome that shapes prognosis and the interpretation of nutrition assessment in cancer and chronic disease, and distinguishing it from reversible undernutrition matters for realistic expectations of nutrition support. This entry explains its definition and mechanisms as educational reference material; it is not a basis for individual diagnosis or treatment.

Epidemiology

Cachexia is common in advanced cancer and in chronic heart, kidney, and lung disease and is associated with poorer function, reduced treatment tolerance, and higher mortality; in cancer it is estimated to contribute substantially to disease-related deaths (Argilés et al., 2014).

Evidence & guidelines

Definition and staging rest on consensus statements — the cross-disease definition of Evans and colleagues (2008) and the cancer-specific international consensus of Fearon and colleagues (2011) — with mechanism summarised in major reviews (Argilés et al., 2014).

History

Wasting in advanced disease has been recognised since antiquity, but a usable modern definition emerged only recently: Evans and colleagues proposed a cross-disease definition in 2008, and Fearon's group published a staged international consensus specific to cancer cachexia in 2011. Mechanistic understanding has since broadened from a muscle-centred view to a multi-organ, inflammation-driven syndrome.

Debates

Can cachexia be reversed by nutrition alone?

Consensus definitions stress that cachexia is not fully reversible by conventional nutritional support because catabolic, inflammation-driven drivers persist, which distinguishes it from starvation and shapes realistic goals of nutrition care.

Key figures

• Kenneth Fearon
• William Evans
• Josep Argilés
• David Cuthbertson

Seminal works

• evans-2008
• fearon-2011
• argiles-2014

Frequently asked questions

Why can't cachexia be fixed just by feeding more?

Cachexia is driven by ongoing inflammation and catabolism from an underlying disease, so muscle loss continues despite extra nutrition; by definition it is not fully reversible by conventional nutritional support alone.

How is cachexia different from sarcopenia?

Cachexia is wasting driven by an underlying illness and systemic inflammation, whereas sarcopenia is loss of muscle mass and strength most often linked to ageing; they overlap but are defined by different criteria and drivers.